The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus (Adv. Sci. 27/2023)

Fang Zhang,Baokai Zhang,Huihua Ding,Xiangyue Li,Xilin Wang,Xiaomin Zhang,Qiaojie Liu,Qiuyun Feng,Mingshun Han,Longlong Chen,Linlin Qi,Dan Yang,Xiaojing Li,Xingguo Zhu,Qi Zhao,Jiaqian Qiu,Zhengjiang Zhu,Huiru Tang,Nan Shen,Hongyan Wang,Bin Wei
DOI: https://doi.org/10.1002/advs.202370181
IF: 15.1
2023-09-27
Advanced Science
Abstract:Systemic Lupus Erythematosus In article number 2207108, Nan Shen, Hongyan Wang, Bin Wei, and co‐workers report elevated plasma levels of 7α,25‐dihydroxycholesterol, but its receptor EBI2 is reduced in monocyte/macrophages from patients and mice with systemic lupus erythematosus (SLE). EBI2‐deficient macrophages produce higher levels of IFN‐I, chemokines and cytokines, which further recruits and activates T and B lymphocytes to exacerbate the development of SLE.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?